Effectiveness of BNT162b2 COVID-19 vaccination in prevention of hospitalisations and severe disease in adults with SARS-CoV-2 Delta (B.1.617.2) and Omicron (B.1.1.529) variant between June 2021 and July 2022: A prospective test negative case-control study.
Lancet Reg Health Eur
; 25: 100552, 2023 Feb.
Article
em En
| MEDLINE
| ID: mdl-36506791
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Tipo de estudo:
Observational_studies
/
Risk_factors_studies
Idioma:
En
Revista:
Lancet Reg Health Eur
Ano de publicação:
2023
Tipo de documento:
Article
País de afiliação:
Reino Unido